Orca Bio Stock

orcabio.comHealthcareFounded: 2016Funding to Date: $291.19MM

Orca Bio is the developer of high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

Register for Details

For more details on financing and valuation for Orca Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Orca Bio.

Register Today

Team

Management Team

Ivan Dimov Ph.D
Co-Founder & Chief Executive Officer
Dan Kirby
Chief Commercial Officer
Jeroen Bekaert
Chief Operating Officer
Nathaniel Fernhoff Ph.D
Co-Founder & Chief Science Officer

Board Members

Alex Kolicich
8VC
Jonathan MacQuitty Ph.D
Lightspeed Venture Partners

Other companies like Orca Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector